Physician profile
Sarah C Studyvin
NPI 1568880227
$2,903.38
in general payments reported to CMS, 2019-2025
17 companies · $165 in 2025
The $165 reported for 2025 was more than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $710 · 2022: $1,574 · 2023: $361 · 2024: $92.87 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $414.16 | 2021-2022 | |
| Inari Medical, INC. | $272.89 | 2022 | |
| Janssen Pharmaceuticals, INC | $244.52 | 2021-2022 | |
| Pfizer INC. | $234.56 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $232.01 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $228.34 | 2021-2022 | |
| Irhythm Technologies, INC. | $212.76 | 2021-2023 | Zio Xt Patch |
| Medtronic, INC. | $192.35 | 2022-2024 | Harmony |
| Abbott Laboratories | $165.03 | 2025 | Amplatzer Piccolo |
| Amgen INC. | $162.58 | 2022 | |
| Novartis Pharmaceuticals Corporation | $161.48 | 2022-2023 | |
| Philips North America LLC | $112.43 | 2022 | |
| Impulse Dynamics (USA) INC. | $82.48 | 2022-2023 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $76.54 | 2023 | Uptravi |
| Abiomed | $41.21 | 2023 | Impella |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $40.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.95 | 2022-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Studyvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.